We would love to hear your thoughts about our site and services, please take our survey here.
Big issue with BEN short term is that the CEO has completed misread the Market for MET B
Huge risk here is that MET B goes below breakeven for a sustained period,
Operation would surely be Mothballed and taken over by Avani
Https://www.lse.co.uk/ShareTrades.html?shareprice=DEST&share=Destiny-Pharma&trade-date=2024-03-04
Davey50 you do realise that the majority of the buying would have been shorts closing.